Table 5

Differences in Clinical Outcomes at Various Compliance Levels Pre- and Post-Yoga

Average Δ From Pre to Post by Average Number of Sessions/Week
≤2>2 and ≤3>3 and ≤4>4
Clinical Outcome Measure(n = 6)(n = 16)(n = 18)(n = 9)p Value
Primary efficacy measures
 Symptomatic episodes with documented AF−2.3 ± 1.9−1.2 ± 1.8−1.7 ± 1.9−1.2 ± 2.30.658
 Symptomatic episodes without documented AF−0.3 ± 2.3−2.0 ± 4.0−1.4 ± 2.1−2.0 ± 2.50.813
 AF episodes−2.7 ± 2.3−1.4 ± 1.7−1.7 ± 1.9−1.2 ± 2.30.692
 Asymptomatic episodes with documented AF−0.3 ± 0.5−0.2 ± 0.50.0 ± 0.00.0 ± 0.00.058
Secondary efficacy measures
 SDS−1.5 ± 13.4−2.7 ± 4.0−3.8 ± 3.5−3.7 ± 7.40.626
 SAS−6.7 ± 6.6−6.9 ± 3.9−7.7 ± 5.2−2.8 ± 5.80.162
SF-36 QoL measures (domain wise)
 1. Physical functioning10.8 ± 15.312.7 ± 19.83.3 ± 12.86.7 ± 11.50.518
 2. Role physical7.5 ± 36.612.7 ± 21.06.4 ± 30.48.3 ± 41.50.543
 3. Bodily pain27.8 ± 44.415.1 ± 36.81.2 ± 26.9−7.3 ± 14.60.061
 4. General health14.2 ± 14.315.5 ± 13.918.3 ± 18.016.4 ± 11.70.985
 5. Vitality7.7 ± 16.111.5 ± 16.18.3 ± 9.07.1 ± 14.90.830
 6. Social functioning14.3 ± 9.51.9 ± 15.25.8 ± 13.05.7 ± 12.90.194
 7. Role emotional11.7 ± 7.55.3 ± 18.02.0 ± 15.4−1.9 ± 19.50.492
 8. Mental health4.2 ± 13.26.2 ± 7.37.1 ± 8.94.1 ± 8.70.907
Hemodynamic parameters
 Systolic BP, mm Hg−5.0 ± 5.4−5.4 ± 4.2−4.8 ± 5.3−6.1 ± 5.30.812
 Diastolic BP, mm Hg−5.7 ± 4.1−5.6 ± 6.7−2.8 ± 9.2−3.9 ± 7.30.887
 Heart rate, beats/min−1.7 ± 3.1−3.5 ± 2.0−3.2 ± 4.4−3.8 ± 2.80.600

QoL = quality of life; abbreviations as in Tables 1 and 2.